Periodic Reporting for period 1 - SupraVir (Multivalent Supramolecular Nanosystems as Dynamic Virus Blockers)
Berichtszeitraum: 2022-10-01 bis 2025-03-31
The evaluations of the SupraVir structures were performed in WP4-5. The structures have been investigated with various biophysical and biological methods. Microscale thermophoresis (MST) was used to investigate the virus binding quantitatively, and cryo-EM was used to visualize virus interactions as WP4. In WP5, for the virus inhibition, they were evaluated by plaque reduction assays, virus infection assays, virucidal assays against multiple viruses, including herpes simplex virus (HSV), influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 etc. 3D in vitro models, such “lung-on-a-chip” models, are being developed for further evaluations.
In the investigation of 2D self-assembly nanosheets, we successfully demonstrated that these self-assembled nanosheets can wrap whole virus particles, leading to irreversible virus interactions. Unlike the state-of-the-art multivalent inhibitors, which primarily target the spike protein of the virus, the 2D supramolecular nanosheets introduce a novel approach to permanently inactivate viruses through a virucidal mechanism. Interestingly, the same 2D nanosheet was also effective in inhibiting the infection of influenza A virus, which utilizes a binding ligand distinct from that of SARS-CoV-2. This finding validates our hypothesis that flexible and dynamic supramolecular structures can adapt to varying virus morphologies, offering broad-spectrum antiviral activity. Furthermore, the nanosheets' low IC50 value (30 nM) not only supports their potential for translational studies, but also inspires further exploration of supramolecular nanostructures for diverse biomedical applications.